VectorY (Drug Discovery) is Drug Discovery in Netherlands that focus on gene therapy business. Founded in 2020. They cover business area such as developer, novel therapy, patient, antibody, gene therapy, scalable manufacturing process, specific cell type, sub-cellular compartment, medical practitioner, limitation, disease area, unmet medical need.
2020
( 4 years old in 2024 )
Gene Therapy
-
Science Park
Matrix Innovation Center 408
1098 XH Amsterdam
Netherlands
Private
developernovel therapypatientantibodygene therapyscalable manufacturing processspecific cell typesub-cellular compartmentmedical practitionerlimitationdisease areaunmet medical need
* We use standard office opening hours in near VectorY (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
VectorY (Drug Discovery) is Drug Discovery business from Netherlands that founded in 2020 (4 years old in 2024), VectorY (Drug Discovery) business is focusing on Gene Therapy.
VectorY (Drug Discovery) headquarter office and corporate office address is located in Science Park Matrix Innovation Center 408 1098 XH Amsterdam Netherlands.
VectorY (Drug Discovery) was founded in Netherlands.
In 2024, VectorY (Drug Discovery) is currently focus on gene therapy sector.
Above is snippet of Google Trends for "gene therapy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with VectorY (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
